| This article has been cited by |
| 1 | Eugenol Attenuates Scopolamine-Induced Hippocampal Cholinergic, Glutamatergic, and Mitochondrial Toxicity in Experimental Rats | |
| Debapriya Garabadu,Mahima Sharma |
| Neurotoxicity Research.2019;35(4)848 |
| [DOI] |
|
| 2 | Protective effects of perindopril against indomethacin-induced gastric mucosal damage through modulation of DDAH-1/ADMA and ACE-2/ANG-(1-7) signaling pathways | |
| Yasmin T. Mohamed,Ibrahim A. Naguib,Ali A. Abo-Saif,Wafaa R. Mohamed |
| Drug and Chemical Toxicology.2022;45(6)2509 |
| [DOI] |
|
| 3 | EFFECT OF AQUEOUS EXTRACT OF CYNODON DACTYLON (DOOB GRASS) ON NORMAL AND IMPAIRED MEMORY IN MICE | |
| SAROJ KOTHARI,MONIKA SAHU |
| Asian Journal of Pharmaceutical and Clinical Research.2022;45(6)130 |
| [DOI] |
|
| 4 | Angiotensin-(1-7)/Mas axis modulates fear memory and extinction in mice | |
| Thiago Luiz do Nascimento Lazaroni,Cristiane Perácio Bastos,Márcio Flávio Dutra Moraes,Robson Souza Santos,Grace Schenatto Pereira |
| Neurobiology of Learning and Memory.2016;127(6)27 |
| [DOI] |
|
| 5 | Perindopril ameliorates experimental Alzheimer’s disease progression: role of amyloid ß degradation, central estrogen receptor and hyperlipidemic-lipid raft signaling | |
| Basim A. S. Messiha,Mohammed R. A. Ali,Mahmoud M. Khattab,Amira M. Abo-Youssef |
| Inflammopharmacology.2020;28(5)1343 |
| [DOI] |
|
| 6 | Endothelial Senescence and Chronic Fatigue Syndrome, a COVID-19 Based Hypothesis | |
| Adonis Sfera,Carolina Osorio,Carlos M. Zapata Martín del Campo,Shaniah Pereida,Steve Maurer,Jose Campo Maldonado,Zisis Kozlakidis |
| Frontiers in Cellular Neuroscience.2021;15(5)1343 |
| [DOI] |
|
| 7 | A Review on the Neurological Manifestations of COVID-19 Infection: a Mechanistic View | |
| Hamid Soltani Zangbar,Ali Gorji,Tahereh Ghadiri |
| Molecular Neurobiology.2021;58(2)536 |
| [DOI] |
|
| 8 | A Comparative Study on the Memory-Enhancing Actions of Oral Renin-Angiotensin System Altering Drugs in Scopolamine-Treated Mice | |
| Daniela Carmen Ababei,Veronica Bild,Alin Ciobica,Radu Marian Lefter,Razvan Nicolae Rusu,Walther Bild |
| American Journal of Alzheimer's Disease & Other Dementias®.2019;34(5)329 |
| [DOI] |
|
| 9 | The Brain AT2R—a Potential Target for Therapy in Alzheimer’s Disease and Vascular Cognitive Impairment: a Comprehensive Review of Clinical and Experimental Therapeutics | |
| Heba A. Ahmed,Tauheed Ishrat |
| Molecular Neurobiology.2020;57(8)3458 |
| [DOI] |
|
| 10 | Development and optimization of chitosan coated nanoemulgel of telmisartan for intranasal delivery: A comparative study | |
| Ling Yuan Chin,Joyce Yi Pei Tan,Hira Choudhury,Manisha Pandey,Sreenivas Patro Sisinthy,Bapi Gorain |
| Journal of Drug Delivery Science and Technology.2021;62(8)102341 |
| [DOI] |
|
| 11 | Time-of-Day and Age Impact on Memory in Elevated Plus-Maze Test in Rats | |
| Nicanor Morales-Delgado,Natalija Popovic,Ernesto De la Cruz-Sánchez,María Caballero Bleda,Miroljub Popovic |
| Frontiers in Behavioral Neuroscience.2018;12(8)102341 |
| [DOI] |
|
| 12 | Beneficial effects of angiotensin converting enzyme inhibition on scopolamine-induced learning and memory impairment in rats, the roles of brain-derived neurotrophic factor, nitric oxide and neuroinflammation | |
| Farimah Beheshti,Hamid Reza Akbari,Yousef Baghcheghi,Fatemeh Mansouritorghabeh,Sakineh Sadat Mortazavi Sani,Mahmoud Hosseini |
| Clinical and Experimental Hypertension.2021;43(6)505 |
| [DOI] |
|
| 13 | Facilitation of TRKB Activation by the Angiotensin II Receptor Type-2 (AT2R) Agonist C21 | |
| Liina Laukkanen,Cassiano R. A. F. Diniz,Sebastien Foulquier,Jos Prickaerts,Eero Castrén,Plinio C. Casarotto |
| Pharmaceuticals.2021;14(8)773 |
| [DOI] |
|
| 14 | Heterologous regulation of the cannabinoid type 1 receptor by angiotensin II in astrocytes of spontaneously hypertensive rats | |
| Dhanush Haspula,Michelle A. Clark |
| Journal of Neurochemistry.2016;139(4)523 |
| [DOI] |
|
